Dr Grant McNaughton-Smith was invited to speak at the Advances in Biomedical REsearch symposium (ABRE2025)

TENERIFE, SPAIN, JULY 21-23, 2025

The presentation covered the history behind the discovery of HsClpP agonists as new potential anticancer agents, and how the CLIP-CAN project will seek to develop new and improved HsClpP agonists, to treat various resistant cancers.

The full video can be watched upon request.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *